Further testing of apixaban in patients at risk of recurrent ischemic events is warranted.
阿哌沙班在再次缺血事件高危患者应用还需要更多临床实验来论证.
互联网
The safety and efficacy of apixaban may vary depending on background antiplatelet therapy.
阿哌沙班的安全性及有效性可能依赖于基础抗血小板治疗而变化.
互联网